PANXEON reads three signals to catch pancreatic cancer sooner
An AI-scored liquid biopsy from City of Hope caught stage 1 and 2 pancreatic cancer 87% of the time in…
Editor's Top Picks
One AI watchdog now covers every ward in Abu Dhabi
A year after launch, the emirate's health department says its AI patient safety platform now connects 100% of hospitals and…
Your one-stop resource for medical news and education.
Hospital CEOs must own AI safety, not delegate it to IT
Three healthcare leaders argue that hospital executives must take direct responsibility for AI oversight, not leave it to committees.
Bristol Myers Squibb partners with Nvidia on AI factory for drug discovery
BMS is building dedicated AI compute infrastructure with Nvidia to accelerate molecular modeling and drug discovery.
Tempus AI acquires Personalis for $1.5B in precision medicine play
Tempus AI adds Personalis' liquid biopsy and tumor sequencing capabilities in a $1.5 billion acquisition.
DiMe and FDA launch joint AI governance toolkit for health systems
The Digital Medicine Society partners with the FDA and 30 organizations to build practical tools for hospital AI governance.
Two health systems deploy Epic’s no-code AI agents in real clinical workflows
Advocate Health and ECU Health deployed AI agents on Epic's Agent Factory platform, cutting chart review time by 20 hours…
Health systems deploy AI agents while wrestling trust and token costs
Health systems moving from pilot AI agents to production face twin challenges: maintaining clinical trust and managing the cost of…
AI-guided technique maps tumor blood supply for precise brain cancer therapy
MD Anderson researchers develop AI-guided technique to map brain tumor blood supply, enabling more precise delivery of targeted therapy.
Belgian techbio startup Sightera raises $3.2M for AI-designed molecular glues
Belgian AI drug discovery startup Sightera Biosciences raises $3.2M to advance molecular glue therapies for hard-to-treat cancers and fibrosis.